Market Tracker

06/22 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.70
Delayed Data
As of 3:59pm ET
 -0.06 / -1.60%
Today’s Change
1.62
Today|||52-Week Range
5.79
+38.58%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.76
Today’s open3.81
Day’s range3.70 - 3.88
Volume334,072
Average volume (3 months)198,917
Market cap$184.7M
Dividend yield--
Data as of 3:59pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-89.73%
P/E ratioNM
Price/Sales434.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc-0.10-5.95%
MNOVMediciNova Inc+0.09+1.65%
MDGLMadrigal Pharmaceuti...+0.37+2.53%
URGNUrogen Pharma Ltd+0.22+1.26%
Data as of 3:59pm ET, 06/22/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$283.6K
Annual profit (last year)-$13.1M
Net profit margin-4,622.39%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts